Related Experiment Videos
Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178
R Medori1, P Montagna, H J Tritschler
1Division of Neuropathology, Case Western Reserve University, Cleveland, OH.
Abstract:
Fatal familial insomnia (FFI), a condition characterized by inability to sleep, dysautonomia, motor disturbances, and selective thalamic atrophy is a prion disease linked to a GAC----AAC mutation at codon 178 of the prion gene. These data were obtained from one kindred. We now report a second kindred affected by FFI and carrying the same mutation. The finding of the same disease phenotype and genotype in a second family further validates FFI as a distinct disease entity and a phenotype of the GAC----AAC mutation at codon 178 of the prion gene.
Insights
Fatal familial insomnia (FFI), a rare prion disease, is confirmed as a distinct entity. The GAC----AAC mutation at codon 178 of the prion gene is validated as its cause in a second family.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Fatal familial insomnia (FFI) is a rare, autosomal dominant prion disease.
- It is characterized by severe insomnia, autonomic dysfunction, and motor deficits.
- Previous studies linked FFI to a specific mutation in the prion gene.
Observation:
- A second kindred exhibiting FFI was identified.
- This family carried the same GAC----AAC mutation at codon 178 of the prion gene as previously reported.
- Clinical and genetic data were consistent across both families.
Findings:
- The GAC----AAC mutation at codon 178 of the prion gene is definitively linked to FFI.
- This mutation leads to a consistent disease phenotype, including selective thalamic atrophy.
- The genetic basis of FFI is further validated.
Implications:
- FFI is confirmed as a distinct disease entity.
- The prion gene mutation serves as a reliable genetic marker for FFI diagnosis.
- Further research into prion disease mechanisms and potential therapies can be informed by these findings.